The YABBY gene SHATTERING1 controls activation rather than patterning of the abscission zone in Setaria viridis.
Yunqing YuHao HuDaniel F VoytasAndrew N DoustElizabeth A KelloggPublished in: The New phytologist (2023)
Abscission is predetermined in specialized cell layers called the abscission zone (AZ) and activated by developmental or environmental signals. In the grass family, most identified AZ genes regulate AZ anatomy, which differs among lineages. A YABBY transcription factor, SHATTERING1 (SH1), is a domestication gene regulating abscission in multiple cereals, including rice and Setaria. In rice, SH1 inhibits lignification specifically in the AZ. However, the AZ of Setaria is nonlignified throughout, raising the question of how SH1 functions in species without lignification. Crispr-Cas9 knockout mutants of SH1 were generated in Setaria viridis and characterized with histology, cell wall and auxin immunofluorescence, transmission electron microscopy, hormonal treatment and RNA-Seq analysis. The sh1 mutant lacks shattering, as expected. No differences in cell anatomy or cell wall components including lignin were observed between sh1 and the wild-type (WT) until abscission occurs. Chloroplasts degenerated in the AZ of WT before abscission, but degeneration was suppressed by auxin treatment. Auxin distribution and expression of auxin-related genes differed between WT and sh1, with the signal of an antibody to auxin detected in the sh1 chloroplast. SH1 in Setaria is required for activation of abscission through auxin signaling, which is not reported in other grass species.
Keyphrases
- cell wall
- single cell
- rna seq
- arabidopsis thaliana
- crispr cas
- wild type
- transcription factor
- poor prognosis
- stem cells
- type diabetes
- genome wide identification
- palliative care
- mesenchymal stem cells
- risk assessment
- genome editing
- skeletal muscle
- ionic liquid
- long non coding rna
- metabolic syndrome
- electron microscopy
- dna methylation
- binding protein
- human health
- polycystic ovary syndrome
- combination therapy
- replacement therapy
- cell fate
- life cycle